リシノプリルの世界市場レポート 2024年

リシノプリル市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR6.4％で22億6,000万米ドルに成長します。予測期間における成長の背景には、高血圧と心血管疾患の有病率の上昇、ジェネリック医薬品の入手可能性とその費用対効果、認知度の向上と早期診断、効果的な治療に対する需要の高まり、高齢化などがあります。この期間の主な動向としては、ドラッグデリバリーの革新、患者中心のドラッグデリバリーアプローチの強化の必要性、費用対効果の高いソリューションの需要、心不全と糖尿病性腎臓病の両方に対する効果的な治療の需要などが挙げられます。

心血管疾患の有病率の増加は、今後数年間のリシノプリル市場の成長を促進すると予想されます。心血管疾患（CVD）には、心臓や血管に影響を及ぼすさまざまな疾患が含まれます。人口の増加、高齢化、危険因子、効果的な予防・治療戦略の欠如など、CVDの有病率上昇にはいくつかの要因があります。リシノプリルは、主に血圧を下げ、心臓や腎臓への負担を軽減することで、心血管疾患の管理に役立ちます。アンジオテンシンIIは血管の拡張を促進し、血液量を減少させ、臓器を損傷から保護します。例えば、米国疾病予防管理センターによると、18歳以上の成人の冠動脈性心疾患の有病率は、2020年の4.6％から2021年には4.9％へとわずかに増加しています。このように、心血管疾患の有病率の上昇がリシノプリル市場の成長を牽引しています。

高血圧の有病率の増加がリシノプリル市場を押し上げると予想されます。高血圧は、動脈壁に対する血液の力が常に高すぎる状態です。不健康な食事、座りっぱなしのライフスタイル、高齢化、長期的なストレスなどの要因が、高血圧の有病率を高めています。リシノプリルは、アンジオテンシンIIの形成を阻害することによって高血圧を効果的に管理し、血管の弛緩、血液量の減少、血圧の低下をもたらします。例えば、世界保健機関（WHO）は2023年3月、世界の30～79歳の成人約12億8,000万人が高血圧症であると報告しました。したがって、高血圧の有病率の増加がリシノプリル市場を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のリシノプリル市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のリシノプリル市場の実績：規模と成長、2018年～2023年
• 世界のリシノプリル市場の予測：規模と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のリシノプリル市場：ブランド別、実績と予測、2018年～2023年、2023年～2028年F、2033年
• ゼストレティック
• プリンビル
• ゼストリル
• その他のブランド
• 世界のリシノプリル市場：疾患別、実績と予測、2018年～2023年、2023年～2028年F、2033年
• 高血圧
• 心不全
• 心臓発作
• ストローク
• 糖尿病性腎臓病
• その他の疾患
• 世界のリシノプリル市場：投与量別、実績と予測、2018年～2023年、2023年～2028年F、2033年
• 錠剤
• 液体
• その他の投与量
• 世界のリシノプリル市場：人口タイプ別、実績と予測、2018年～2023年、2023年～2028年F、2033年
• 子供
• 大人
• 世界のリシノプリル市場：エンドユーザー別、実績と予測、2018年～2023年、2023年～2028年F、2033年
• 病院
• 専門クリニック
• その他のエンドユーザー

第7章 地域別・国別分析

• 世界のリシノプリル市場：地域別、実績と予測、2018年～2023年、2023年～2028年F、2033年
• 世界のリシノプリル市場：国別、実績と予測、2018年～2023年、2023年～2028年F、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• リシノプリル市場：競合情勢
• リシノプリル市場：企業プロファイル
  • Merck & Co. Inc.
  • Pfizer Inc.
  • AbbVie Inc.
  • AstraZeneca Plc
  • Vitaris Inc.

第31章 その他の大手企業と革新的企業

• Teva Pharmaceutical Industries Limited
• Bausch Health Companies Inc.
• Hetero Ltd.
• Sun Pharmaceutical Industries Limited
• Aurobindo Pharma Ltd.
• Cipla Inc.
• Hikma Pharmaceutical Plc
• Apotex Inc.
• Amneal Pharmaceutical Inc.
• Lupin Ltd.
• Zhejiang Huahai Pharmaceutical Co. Ltd.
• Metrochem API Private Limited
• Calyx Chemicals & Pharmaceuticals Limited
• Farmhispania Group
• Zydus Cadila Healthcare Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

Lisinopril is a medication classified as an angiotensin-converting enzyme (ACE) inhibitor. It works by reducing certain chemicals that tighten blood vessels, facilitating smoother blood flow and improving the heart's pumping efficiency. Lisinopril is prescribed for adults to treat congestive heart failure and to increase survival rates after a heart attack.

The main brands of lisinopril include Zestoretic, Prinivil, Zestril, among others. Zestoretic is a combination medication containing lisinopril, an ACE inhibitor, and hydrochlorothiazide, a thiazide diuretic. It is used to treat conditions such as hypertension, heart failure, heart attacks, strokes, diabetic kidney disease, among others. It is available in various forms such as tablets and liquid, and is prescribed to different populations including children and adults. These medications are used by various end-users such as hospitals, specialty clinics, and others.

The lisinopril market research report is one of a series of new reports from The Business Research Company that provides lisinopril market statistics, including lisinopril industry global market size, regional shares, competitors with a lisinopril market share, detailed lisinopril market segments, market trends, and opportunities, and any further data you may need to thrive in the lisinopril industry. This lisinopril market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lisinopril market size has grown strongly in recent years. It will grow from $1.66 billion in 2023 to $1.76 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth during the historic period can be attributed to increased accessibility, lifestyle changes, expanded screening programs, greater availability of generic lisinopril, and improved patient adherence.

The lisinopril market size is expected to see strong growth in the next few years. It will grow to $2.26 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to the rising prevalence of hypertension and cardiovascular diseases, the availability of generic versions and their cost-effectiveness, increased awareness and early diagnosis, the growing demand for effective treatments, and an aging population. Major trends during this period include innovations in drug delivery, the need for enhanced and patient-centric drug delivery approaches, the demand for cost-effective solutions, and the demand for effective treatments for both heart failure and diabetic kidney disease.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the lisinopril market in the coming years. Cardiovascular diseases (CVDs) include a variety of disorders affecting the heart and blood vessels. Several factors contribute to the rising prevalence of CVDs, such as population growth, aging, risk factors, and the lack of effective prevention and treatment strategies. Lisinopril helps manage cardiovascular diseases mainly by lowering blood pressure and reducing the strain on the heart and kidneys. It works by inhibiting the production of angiotensin II, which facilitates blood vessel dilation, reduces blood volume, and protects organs from damage. For example, according to the Centers for Disease Control and Prevention, the prevalence of coronary heart disease among adults aged 18 and over increased slightly from 4.6% in 2020 to 4.9% in 2021. Thus, the rising prevalence of cardiovascular diseases is driving the growth of the lisinopril market.

The growing prevalence of hypertension is expected to boost the lisinopril market. Hypertension, or high blood pressure, is a condition where the force of blood against artery walls is consistently too high. Factors such as an unhealthy diet, sedentary lifestyle, aging population, and long-term stress contribute to the increasing prevalence of hypertension. Lisinopril effectively manages hypertension by blocking the formation of angiotensin II, leading to blood vessel relaxation, reduced blood volume, and lower blood pressure. For instance, the World Health Organization reported in March 2023 that around 1.28 billion adults aged 30-79 worldwide had hypertension. Therefore, the increasing prevalence of hypertension is driving the lisinopril market.

In January 2024, Sun Pharmaceutical Industries Limited, an Indian pharmaceutical company, acquired Taro Pharmaceutical Industries Ltd for $347.73 million. This acquisition allows Sun Pharma to expand its portfolio by incorporating Taro's expertise in generic and specialty medicines, active pharmaceutical ingredients (APIs), and over-the-counter products. Taro Pharmaceutical Industries Ltd, a US-based company, offers lisinopril.

Major companies operating in the lisinopril market are Merck & Co. Inc., Pfizer Inc., AbbVie Inc., AstraZeneca Plc, Vitaris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Hetero Ltd., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Ltd., Cipla Inc., Hikma Pharmaceutical Plc, Apotex Inc., Amneal Pharmaceutical Inc., Lupin Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Metrochem API Private Limited, Calyx Chemicals & Pharmaceuticals Limited, Farmhispania Group, Zydus Cadila Healthcare Ltd., Qingdao Qingmei Biotech Co. Ltd., LGM Pharma LLC, Amara Labs Pvt., Sms Lifesciences

North America was the largest region in the lisinopril market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lisinopril market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lisinopril market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lisinopril market consists of sales of prinivil, qbrelis, zestoretic, zestril and apo-lisinopril. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lisinopril Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lisinopril market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lisinopril ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lisinopril market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Brand: Zestoretic; Prinivil; Zestril; Other Brands
• 2) By Disease: Hypertension; Heart Failure; Heart Attack; Strokes; Diabetic Kidney Disease; Other Diseases
• 3) By Dosage: Tablet; Liquid; Other Dosages
• 4) By Population Type: Children; Adults
• 5) By End-Users: Hospitals; Specialty Clinics; Other End-Users
• Companies Mentioned: Merck & Co. Inc.; Pfizer Inc.; AbbVie Inc.; AstraZeneca Plc; Vitaris Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lisinopril Market Characteristics

3. Lisinopril Market Trends And Strategies

4. Lisinopril Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Lisinopril Market Size and Growth

• 5.1. Global Lisinopril Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Lisinopril Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Lisinopril Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Lisinopril Market Segmentation

• 6.1. Global Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Zestoretic
• Prinivil
• Zestril
• Other Brands
• 6.2. Global Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hypertension
• Heart Failure
• Heart Attack
• Strokes
• Diabetic Kidney Disease
• Other Diseases
• 6.3. Global Lisinopril Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Tablet
• Liquid
• Other Dosages
• 6.4. Global Lisinopril Market, Segmentation By Population Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Children
• Adults
• 6.5. Global Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Specialty Clinics
• Other End-Users

7. Lisinopril Market Regional And Country Analysis

• 7.1. Global Lisinopril Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Lisinopril Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Lisinopril Market

• 8.1. Asia-Pacific Lisinopril Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Lisinopril Market

• 9.1. China Lisinopril Market Overview
• 9.2. China Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Lisinopril Market

• 10.1. India Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Lisinopril Market

• 11.1. Japan Lisinopril Market Overview
• 11.2. Japan Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Lisinopril Market

• 12.1. Australia Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Lisinopril Market

• 13.1. Indonesia Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Lisinopril Market

• 14.1. South Korea Lisinopril Market Overview
• 14.2. South Korea Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Lisinopril Market

• 15.1. Western Europe Lisinopril Market Overview
• 15.2. Western Europe Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Lisinopril Market

• 16.1. UK Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Lisinopril Market

• 17.1. Germany Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Lisinopril Market

• 18.1. France Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Lisinopril Market

• 19.1. Italy Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Lisinopril Market

• 20.1. Spain Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Lisinopril Market

• 21.1. Eastern Europe Lisinopril Market Overview
• 21.2. Eastern Europe Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Lisinopril Market

• 22.1. Russia Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Lisinopril Market

• 23.1. North America Lisinopril Market Overview
• 23.2. North America Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Lisinopril Market

• 24.1. USA Lisinopril Market Overview
• 24.2. USA Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Lisinopril Market

• 25.1. Canada Lisinopril Market Overview
• 25.2. Canada Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Lisinopril Market

• 26.1. South America Lisinopril Market Overview
• 26.2. South America Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Lisinopril Market

• 27.1. Brazil Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Lisinopril Market

• 28.1. Middle East Lisinopril Market Overview
• 28.2. Middle East Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Lisinopril Market

• 29.1. Africa Lisinopril Market Overview
• 29.2. Africa Lisinopril Market, Segmentation By Brand, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Lisinopril Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Lisinopril Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Lisinopril Market Competitive Landscape And Company Profiles

• 30.1. Lisinopril Market Competitive Landscape
• 30.2. Lisinopril Market Company Profiles
  • 30.2.1. Merck & Co. Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Pfizer Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. AbbVie Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AstraZeneca Plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Vitaris Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Lisinopril Market Other Major And Innovative Companies

• 31.1. Teva Pharmaceutical Industries Limited
• 31.2. Bausch Health Companies Inc.
• 31.3. Hetero Ltd.
• 31.4. Sun Pharmaceutical Industries Limited
• 31.5. Aurobindo Pharma Ltd.
• 31.6. Cipla Inc.
• 31.7. Hikma Pharmaceutical Plc
• 31.8. Apotex Inc.
• 31.9. Amneal Pharmaceutical Inc.
• 31.10. Lupin Ltd.
• 31.11. Zhejiang Huahai Pharmaceutical Co. Ltd.
• 31.12. Metrochem API Private Limited
• 31.13. Calyx Chemicals & Pharmaceuticals Limited
• 31.14. Farmhispania Group
• 31.15. Zydus Cadila Healthcare Ltd.

32. Global Lisinopril Market Competitive Benchmarking

33. Global Lisinopril Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lisinopril Market

35. Lisinopril Market Future Outlook and Potential Analysis

• 35.1 Lisinopril Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Lisinopril Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Lisinopril Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer